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Abstract
Person-to-person transmission of influenza viruses occurs by contact (direct and fomites) and non-contact (droplet and
small particle aerosol) routes, but the quantitative dynamics and relative contributions of these routes are incompletely
understood. The transmissibility of influenza strains estimated from secondary attack rates in closed human populations is
confounded by large variations in population susceptibilities. An experimental method to phenotype strains for
transmissibility in an animal model could provide relative efficiencies of transmission. We developed an experimental
method to detect exhaled viral aerosol transmission between unanesthetized infected and susceptible ferrets, measured
aerosol particle size and number, and quantified the viral genomic RNA in the exhaled aerosol. During brief 3-hour
exposures to exhaled viral aerosols in airflow-controlled chambers, three strains of pandemic 2009 H1N1 strains were
frequently transmitted to susceptible ferrets. In contrast one seasonal H1N1 strain was not transmitted in spite of higher
levels of viral RNA in the exhaled aerosol. Among three pandemic strains, the two strains causing weight loss and illness in
the intranasally infected ‘donor’ ferrets were transmitted less efficiently from the donor than the strain causing no
detectable illness, suggesting that the mucosal inflammatory response may attenuate viable exhaled virus. Although
exhaled viral RNA remained constant, transmission efficiency diminished from day 1 to day 5 after donor infection. Thus,
aerosol transmission between ferrets may be dependent on at least four characteristics of virus-host relationships including
the level of exhaled virus, infectious particle size, mucosal inflammation, and viral replication efficiency in susceptible
mucosa.
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Introduction
Seasonal influenza virus is a highly contagious respiratory
pathogen that causes over one million infections and is associated
with approximately 3000 up to 49,000 deaths each year in the
United States [1]. Infections due to the 2009 H1N1 pandemic
influenza virus were primarily self-limited with the highest attack
rates among children and young adults [2]. Future pandemics
could theoretically duplicate the high virulence of the 1918
pandemic [3,4]. In addition to pre-pandemic vaccination, non-
pharmaceutical interventions such as social distancing may have
important roles in reducing transmission. The current poor
quantitative understanding of influenza transmission could impair
the development of evidence-based interventions [5,6].
Transmission is classified as three modes, by direct contact with
infected persons or indirect contact with contaminated fomites, by
inhaling large droplets (droplet spray) within a meter of the source,
or by small particle aerosols exhaled during talking, coughing or
breathing [7,8]. Reviews of influenza transmission among human
populations have concluded that transmission is by contact and
droplet spray [9,10] while others conclude that aerosol transmis-
sion contributes significantly to spread of infection [11,12].
Transmissibility is currently estimated from the spread of influenza
in relatively closed populations and is expressed as the number of
secondary infections derived from one contagious person (basic
reproductive number R0). The R0 for the 2009 H1N1 pandemic
strain has been estimated to range from 1.4 to 1.8 [13–16], values
that overlap with the R0 of seasonal strains of 1.7–2.1 [17] and
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however, is complicated by unmeasured human variables
including contact behavior and pre-existing immunity [19].
A quantitative measure of strain transmissibility independent
of human variables would be useful in predicting epidemic
potential. Transmissibility in an animal model is the combina-
tion of four serial components, first a threshold viral load in the
respiratory mucosa of the contagious host, then exhalation of
virus, survival of airborne virus, and finally replication kinetics
of inhaled virus in susceptible mucosa [20]. Ferrets have served
as a transmission model mimicking many features of human
transmission [21,22]. Key viral genotypic features in the
hemagglutinin and PB2 segments related to relative transmissi-
bility have been described in multiple subtypes [23–27]. Studies
of non-contact droplet (aerosol) transmission between ferrets
have utilized continuous exposures in a side-by-side cage design
to identify relative differences in transmissibility between strains.
Under these conditions H5N1 avian-origin viruses were not
transmitted [28], whereas seasonal strains were readily trans-
mitted, and pandemic strains were transmitted as readily [29] or
less readily [30] than seasonal strains. Recently, the aerosol ID50
has been measured for two seasonal influenza strains in the
ferret model [31,32].
Our goals in this study included measuring the viral load in
the exhaled aerosol under controlled airflow conditions and
exposing susceptible ferrets to exhaled aerosols for only 3 hours
to approximate the duration of typical human exposures. We
examined ferret-to-ferret exhaled viral aerosol transmission for
one seasonal and three pandemic H1N1 strains. Ferrets infected
with the seasonal virus exhaled higher levels of virus than those
infected with the pandemic strains, yet transmission of the
pandemic strains was significantly more efficient than the
seasonal strain.
Methods
Virus
Three strains of swine-origin pandemic 2009 H1N1 viruses A/
California/04/2009 (Cal/04), A/Mexico/4482/2009 (Mex/4482)
and A/California/07/2009 (Cal/07), and one seasonal H1N1
strain A/New Caledonia/20/99 (NC/99) were plaque-purified
stocks obtained from the Influenza Division, Centers for Disease
Control, with a history of two passages in embryonated eggs, and
two passages in MDCK cells. Working stocks were prepared from
two passages in embryonated eggs, aliquoted, and stored at
280uC up to four months until needed. The 2009 H1N1 viruses
(Cal/04:FJ966079; Cal/07:FJ984387; Mex/4482:CY098505)
were sequenced after passage to assure preservation of the
consensus sequences according to the NIH Influenza Database.
Virus inocula were titered before inoculation by the focus
neutralization assay (FFU) and embryonated egg infection
(EID50 or 50% egg infectious dose) and after each inoculation
for FFU. Aliquots were thawed at 4uC and diluted in PBS to
10
6 FFU/mL for ferret inoculation. The titer of 10
6 FFU was
approximately equivalent to 1.2–1610
6 EID50 depending on the
experiment. Donor ferrets were inoculated intranasally (i.n.) with
10
6 FFU/mL, 0.5 mL in each naris. In one experiment donor
ferrets were inoculated by both the i.n. and intratracheal (i.t.)
routes with a combined total dose of 10
6 FFU/mL. In one
experiment donor ferrets were infected by nebulized virus as
previously described [32]. Estimated delivered dose was
calculated from viral RNA measured in the nebulized aerosol
as described in the text.
Animals
Outbred castrated male ferrets (Mustela putorius furo) were
obtained from Triple F Farms (Sayre, PA) at 12218 weeks old,
were quarantined for 14 days and weighed 1.0–1.2 kg when
exposed to the viruses. Ferrets were uniquely identified by ear tags
and subcutaneous transponders (IPTT-300; Bio Medic Data
Systems Inc, Seaford, Delaware). Ferrets were pair- or triple-
housed in plastic cages with perforated plastic bottoms (Model RB
272718UP6 Rabbit cage modified to hold ferrets; Allentown Cage
Inc, Allentown, NJ) during the quarantine period but singly
housed after viral exposure in ventilated cages to prevent cross
infection by isolating the air entering and leaving each cage.
Excreta pans under the cages, cage flooring, and room floors were
cleaned daily. All procedures were conducted under protocols
approved by the Institutional Animal Care and Use Committee
(IACUC) at Lovelace Respiratory Research Institute (permit #08-
011), all facilities were accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
International (AAALAC). Guidelines for ferret housing and
environment described in the Guide for the Care and Use of
Laboratory Animals, Seventh Edition, National Research Council,
were strictly adhered to.
Aerosol Exposure Apparatus
Two exposure apparatuses were fabricated each consisting of a
donor (infected ferret) chamber and a recipient (susceptible ferret)
chamber with wire screens between the chambers to prevent direct
contact (Figure 1A, B). The slightly smaller apparatus had a
767615 cm long tunnel between the chambers and the larger
apparatus had a screened 2 cm passage between the chambers.
Air-flow was left-to-right, drawn into the left (donor) chamber at
12 L/min by controlled vacuum. In the tunnel or space between
the donor and recipient chambers, three air sampling ports for
polytetrafluoroethylene (PTFE) filters (Teflon, 37-mm, 2-m pore-
size, Pall Life Sciences, NY) each withdrew 2 L/min, and a fourth
port drew 1 L/min into a laser particle counter (Grimm). Air at
6 L/min entered the right (recipient ferret) chamber, was mixed
by a fan and was removed through two HEPA filters in the right-
side wall. Humidity (RH) and temperature were controlled by
ambient laboratory air at approximately 45% (range 41–48) RH
and 22uC respectively. After exposure, filters were put in 1ml
serum-free media and vigorously vortexed for 20 seconds, the filter
removed, a 500ml aliquot placed into 500ml of RNABee (Amsbio,
Lake Forest, CA)and frozen at 280uC for RNA extraction, and
the remaining fluid was frozen at 280uC for viral culture. After
each exposure the chambers were washed with 1% bleach solution
followed by repeated isopropyl alcohol rinses to remove all traces
of viable virus and viral RNA. For the experiments infecting donor
ferrets by nebulized virus, a six-jet Collison generator was loaded
with 20 mL Eagles Minimal Essential Media and antifoam (Sigma)
as previously described [32].
Clinical Observations
Following aerosol challenge, ferrets were observed twice daily
for symptoms including sneezing, cough, nasal discharge,
respiratory distress, reduction in activity, neurologic signs, or
abnormal behavior. Activity was scored using standard criteria
(0=alert and playful, 1=alert but playful only when stimulated,
2=alert but not playful when stimulated, and 3=neither alert nor
playful when stimulated). Temperature was measured by tran-
sponder from two subcutaneous microchips (IPTT-300 Implant-
able Programmable Temperature and Identification Transponder;
Bio Medic Data Systems, Inc, (BMDS) Seaford, DE 19973)
implanted over the shoulder and hip regions and recorded by
Influenza Aerosol Transmission in Ferrets
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the average of the two readings twice daily.
Pathology
Ferrets were necropsied at protocol-determined intervals after
exposure in order to image the gross lung pathology, measure viral
load in upper respiratory tract, trachea and lung tissue, and assess
the histological extent of infection. Lung lobe samples, trachea,
nasal turbinates, liver, spleen, tracheobronchial lymph nodes,
brain, and olfactory bulbs were processed for viral load and
histopathology; results of extrapulmonary tissues will be reported
elsewhere. Tissues for histopathology were fixed in 4% parafor-
maldehyde, embedded in paraffin, sectioned at 4 to 6 mm, stained
with hematoxylin and eosin, and read by a veterinary pathologist
without knowledge of the infection history. Selected lung tissue
was fixed in methanol prior to incubation with anti-nucleoprotein
antibody (Clontech) to correlate location of influenza antigen with
histological characteristics of epithelial cell infection.
Viral Load
Sample collection, viral culture, RNA isolation, RT-qPCR and
T5000
TM assays were performed as previously described [32].
Viral load was determined by standard tissue culture on MDCK
cells reported as focus-forming units (FFU) and also by real-time
quantitative RT-qPCR. For aerosol samples collected from PTFE
filters, viral genomic RNA was measured by two PCR-based
assays, a standard RT-qPCR detecting nucleocapsid gene RNA
(Lovelace Respiratory Research Institute [LRRI]), and a more
sensitive experimental RT-PCR-based system using time-of-flight
mass spectroscopy analysis of amplimers to detect six influenza A
segments (T5000
TM Biosensor System, Ibis Biosciences, Abbott
Molecular) [33,34]. Since recipient nasal washes were not cultured
daily, but recipients had persistently positive viral RNA assays in
daily throat swabs, infection was defined either by positive culture
or by positive viral RNA levels .10
7 genome equivalents (Geq) for
three or more consecutive days [32]. Data on viral RNA in aerosol
samples are reported only for the more sensitive T5000 assay
unless noted as a comparison of the two assays.
Calculation of Inhaled Virus
The viral RNA collected from the aerosol and analyzed by the
T5000 assay was used to calculate the infectious virus dose inhaled
by the exposed recipient ferret according to the formula:
Virus inhaled=(Geq vRNA/h)*(FFU/Geq ratio)*(MV/filter
sample flow rate).
The FFU/Geq ratio was derived from 4 Teflon filter
collections of high levels of aerosolized virus with positive culture
and viral RNA data. The fraction of air inhaled was calculated
from the minute ventilation (MV) divided by the airflow/min
entering the recipient chamber (6 L/min). Minute ventilation
was estimated from unpublished data and literature reports,
adjusted for ferret weight and sedation status. For anesthetized
ferrets weighing 280 g and 560 g, tidal volumes (TV) have been
reported as 4.0 and 6.0 mL, respectively [35,36]. TV for our
ferrets weighing between 1.0 and 1.2 kg was calculated as
9.0 mL according to the L-power relationship between body
weight and lung volume. The breathing rate (RR) was observed
to be a mean of 35/min (range 28–43), and the lack of sedation
was adjusted by multiplying the TV by 1.5 (J Mauderly, personal
communication), yielding a calculated MV (TV*RR*1.5) of
472 mL/min.
The aerosol ID50 was estimated using Proc Probit in SAS 9.1
(Cary, NC) employing data from Figure 7 on calculated inhaled
virus and whether or not the recipient ferret was infected
according to criteria described in Methods, viral load.
Results
Aerosol Characteristics
Sampling of aerosol particles entering the recipient chambers
showed similar particle size profiles for the two exposure chambers
(Figure 2) except for the largest particles. The fraction of airborne
particles .5 mm reaching the recipient chamber was 0% in the
side-by-side exposure apparatus and 1% in the tunnel exposure
apparatus. Total number of aerosolized particles per minute
passing through the tunnel varied markedly during the typical 3-
hour exposure, depending in part on the observed activity of the
donor ferret (Figure 3).
Exhaled Aerosol Transmission Required a Donor
Threshold Viral Load
Pairs of donor ferrets were infected i.n. with 10
6 FFU of Cal/04
and 3 recipients were exposed in the tunneled chambers to the
Figure 1. Exposure chambers. A. Photograph of tunnel exposure
chamber occupied by two sleeping ferrets in the left donor chamber
and two active ferrets in the right ‘recipient’ chamber. Note that
experiments are described with two ferrets in the donor chamber but
no experiments were performed with two ferrets in the recipient
chamber. A line diagram of this exposure chamber appears in reference
32. Air is drawn through HEPA filters in the left wall of the donor
chamber (left side of photograph) passes through the tunnel where
particle size and PTFE filter ports are located, and is withdrawn through
the recipient chamber (right side) and exits through two ports into
HEPA filters (not visible in photograph). B. Exploded view of exposure
chamber without tunnel between donor and recipient ferret, designed
to more closely approximate conditions of side-by-side cage exposures
in published ferret-model aerosol transmission studies.
doi:10.1371/journal.pone.0033118.g001
Influenza Aerosol Transmission in Ferrets
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e33118donor pair for 3 h approximately 24 h after donor infection.
Exposures to ferrets with low viral loads in nasal wash (Figure 4,
left graph) did not result in transmission indicated by negative
cultures in the recipients, whereas exposure to culture-positive
ferrets resulted in transmission and positive nasal wash cultures
(right graph). Positive cultures in the donors and recipients
correlated with levels of viral RNA .10
7 GEq in these
experiments reported here and for a seasonal H1N1 virus [32].
Thus the level of mucosal viral load in the donor determined in
part donor contagion under these experimental conditions.
Comparison of Transmission after Exposures for 3 or
20 Hours
To compare previously published continuous exposures (.24h)
in side-by-side cages [26–31] with 3 h exposures in similar cages,
donor ferrets were infected i.n. with 10
6 FFU of Cal/04, and one
day later susceptible ferrets were exposed to donor exhaled viral
aerosols. Infection was monitored by nasal washes twice and throat
swabs daily for 5-days post-exposure (dpe) (Figure 5). The two
recipients exposed for 20 hours lost weight and had high levels of
viral RNA for 5 days. In contrast, recipients exposed for only
3 hours had lower levels of viral RNA in the throat below the
threshold of infection.
Contagion Induced by Nebulized Virus
Infection of donor ferrets by the intranasal route versus
inhalation of nebulized virus could possibly induce differing
efficiencies of contagion. Two donor ferrets were infected during
a 1-hour exposure to nebulized Cal/04 virus, calculated to
deliver a dose of 10
6 FFU approximating the intranasal doses
used above. In contrast to intranasal inoculation donors infected
by nebulized virus had decreased activity 226 days post-
inhalation (dpi), sneezing 227 dpi, diarrhea 228 dpi, elevated
temperature .2.5uC above baseline at 5 dpi and loss of 6%
and 11% of body weight, respectively. Each ferret exposed to
one donor in the chamber continuously for four days had
temperature elevations .2.0uC on dpi 327 and 5, respectively,
and loss of 5.6% and 7.7% body weight, respectively, but
without sneezing or diminished activity. Donors had high viral
load in the throat at 1 dpi after nebulized virus exposure,
whereas the recipient ferrets had high viral load delayed until 4
days post-exposure (dpe) after exhaled aerosol exposure
(Figure 6A). Donor-exhaled viral RNA aerosol levels were
highest at 1 dpi and were quantitatively similar to the nebulized
viral RNA levels delivered to the donors during the 1-hour
exposure at 0 dpi (Figure 6B). Thus, contagion induced by
nebulized virus appeared to be at least as potent as that induced
Figure 2. Distribution of particle dimensions delivered to recipient chamber. Particle diameter measured by laser light scattering plotted as
log10 particles per liter of air divided into 24 diameter cohorts ranging from 0.25 microns to 12.5 microns. Particles sampled during 10 min. intervals
with sampling airflow at 1.0 Lt/min and with one resting ferret infected with Cal/04 virus in donor chamber. Top graph: In side-by-side chamber
sampling collected during the middle (green) and end (blue) of the same exposure period, and during an interval of no directed airflow when
vacuum is off (control, red) particle numbers of all size cohorts decreased more than 100-fold. Bottom graph: In tunnel exposure chamber samples
collected during first hour (blue), second hour (red) and third hour (green) of continuous 3 hour exposure.
doi:10.1371/journal.pone.0033118.g002
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symptomatic recipients. Additional head-to-head comparisons
are needed, however, to identify any significant differences in
infections transmitted by inhaled aerosol from nebulized virus
inhalation versus liquid droplet inoculation.
Aerosol Transmission During Early and Late Donor
Infection
Observations in human infections have indicated that
optimum contagion occurs during early infection prior to
symptom appearance. To test for more efficient transmission
in early infection, recipients were exposed to single donors 1, 3,
Figure 3. Particle Concentration variation during chamber exposure. Airborne particles were measured continuously by Grimm
spectrometer and recorded as particles per liter of air in this typical exposure. Particle numbers per second vary over two orders of magnitude.
doi:10.1371/journal.pone.0033118.g003
Figure 4. Exhaled aerosol transmission requires a donor threshold viral load. Two pairs (designated A and B) of donor ferrets (designated
donor1 and donor2 of pair A, donor3 and donor4 of pair B) were infected i.n. and i.t. with a total dose of 10
6 FFU of Cal/04. Three recipients (R1, R2,
R3 exposed to pair A; R4, R5, R6 exposed to pair B) were exposed individually to one of the donor pairs for 3 h approximately 24 h after donor
infection. Exposures to donor ferrets Donor1 and Donor2 with low viral loads in nasal wash (green and red, left graph) did not result in transmission
indicated by negative cultures (yellow squares) in each of the 3 recipients, whereas exposure to ferrets with higher titers of nasal wash virus (red bar)
resulted in transmission and positive nasal wash cultures (yellow bars, right graph). Viral RNA (‘PCR’) is expressed as genome equivalents/mL nasal
wash; Viral culture (‘virus’) is expressed as FFU/mL nasal wash.
doi:10.1371/journal.pone.0033118.g004
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e33118Figure 5. Aerosol transmission is more efficient after 20 h- than 3 h- exposures. Viral RNA (log10 genome equivalents (GEq) in total sample)
in throat swabs from four donors (Do, red) infected intranasally 24 hours previously with Cal/04, and in four recipients (R, blue) each exposed to
exhaled aerosols of one of the donors for either 3 hours (A and B) or 20 hours (C and D).
doi:10.1371/journal.pone.0033118.g005
Figure 6. Aerosol Transmission from donors infected by aerosolized virus. Transmission of Cal/04 between donors infected by nebulized
virus and recipients exposed continuously for 4 days. A. Serial viral RNA titers from throat swabs of donors and recipients, and samples of aerosols
collected during continuous exposures, measured by single-target RT-qPCR. B. Viral RNA captured on PTFE filters during a 1 hour interval each day
after donor ferret infection, and measured by T5000 assay.
doi:10.1371/journal.pone.0033118.g006
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loads in the upper respiratory tract were comparable among the
three pandemic H1N1 strains by both culturable virus
(approximately 10
4 FFU/mL) and levels of viral RNA (6–9
log10 genome equivalents/mL) for most donors of each strain
(Figure 7). The exhaled viral RNA levels from each donor also
were not significantly different among the three strains. No
correlation between level of airborne viral RNA and subsequent
transmission could be drawn, however, as six exposures resulted
in transmission in the absence of detectable viral RNA in the
aerosol. One day and 3 days after donor instillation of Cal/04,
all exposed recipients were infected by viral RNA criteria and
half by culture-positive criteria. None of the 3 ferrets exposed to
culture-positive day 5 Cal/04-infected donors were infected.
When results from all three strains are combined, donors on
their fifth day of infection were significantly less likely to infect
recipients by the viral RNA criteria (5/11 vs 11/11 on dpi 1,
p=0.006, Fisher’s exact test). Transmission from Mex/4482-
and Cal/07-infected donors was reduced 3 and 5 days after
inoculation likely due to fewer culture-positive nasal washes or
throat swabs in the donors.
Comparison of Transmission Efficiency between 1
Seasonal and 3 Pandemic H1N1 Strains
Nebulized seasonal virus NC/99 was infectious to ferrets with a
low aerosol ID50, although culturable virus was rarely present in
the upper airways [32]. To test whether this strain could be
transmitted by exhaled aerosol, donor ferrets were infected i.n.
with 10
6 FFU of NC/99, or one of the three pandemic 2009
H1N1 strains as described above, and susceptible ferrets were
exposed to their exhaled aerosols 1 day later (summarized in
Figure 8A). Using the criterion of viral load either by culture or
by viral RNA, there was no evidence that NC/99 was transmitted
in any of 10 exposures using either a pair of infected donors
(double dose) or a single infected donor. In contrast, all 12
exposures to single Cal/04-infected ferrets resulted in infections,
half detected by culture and the remainder by RT-qPCR and the
T5000 assay. Almost all of the ferrets infected with the other two
2009 H1N1 pandemic strains had evidence of infection by viral
RNA in the throat and nasal wash, but only 1 of 16 had positive
cultures, as noted in Figure 7. No Cal/07-exposed ferrets
developed culture-positive infections, significantly fewer than those
in Cal/04 infections (Fisher exact test, p=0.006).
Intranasal inoculation of the donor ferrets induced varying
degrees of illness depending on the pandemic H1N1 strain.
Donors infected with Cal/04 transmitted more culture-positive
infections, yet exhibited the least weight loss (Figure 8B), no
gross lung pathology (Figure 8C) and the fewest respiratory
symptoms (Table 1). In contrast, Cal/07 donors experienced
the most weight loss, the most apparent pulmonary inflamma-
tion at necropsy (Figure 8C) and the most respiratory
symptoms (Table 1), yet failed to transmit culture-positive
infection (Figure 7). The Mex/4482 virus was intermediate
between the two other strains in these measures of illness. This
apparent inverse relationship between less disease and more
efficient transmission requires more comparative investigations
to extend these observations, but suggests an effect of the
inflammatory response on aerosol transmission.
Relationship of Exhaled Viral RNA Levels to Transmission
A higher viral load in upper airway mucosa might be expected
to result in more efficient aerosol transmission. Higher donor viral
load in Cal/04 infection was associated with transmission in
Figure 4, and in all experiments donor ferrets with less than
3 log10 FFU/nasal wash cultures never transmitted culture-
positive infection, consistent with a donor threshold. On the other
hand, donors with high levels of culturable pandemic H1N1 virus
in nasal wash failed to transmit infection. Levels of virus in exhaled
aerosols might be a more direct measure of contagion but
measured viral RNA in exhaled aerosols was not clearly related to
transmission of the pandemic H1N1 strains (Figure 7). Levels of
viral RNA in exhaled aerosols were compared between the
nasal-wash culture-positive NC/99-infected donors and the NW
culture-positive Cal/04-infected donors. Under identical expo-
sure conditions the NC/99 virus was not transmitted, compared
to frequent transmission of Cal/04, yet NC/99-infected donors
exhaled significantly higher levels of viral RNA measured by
either assay than Cal04-infected donors (Figure 9). Transmis-
sion of Cal/04 occurred in spite of viral RNA-negative 1 h filter
collections, likely attributable to highly variable levels of exhaled
virus during the 3 h exposure.
Source of Exhaled Virus
Exhaled virus from contagious ferrets may be derived from both
upper airway mucosa and small airways within the lung, and thus
upper airway cultures may not reflect the total source of the
exhaled viral aerosol. Viral load for each of the four influenza
viruses was graphed according to both the upper airway viral RNA
load and viral RNA levels in the lung of donor ferrets assessed on
the day of exposure (Figure 10). Cal/07- and Mex/4482-infected
ferrets had significantly higher viral loads measured by viral RNA
levels in lung tissue than Cal/04-infected ferrets (p=0.007), but
these higher viral loads were associated with lower rates of
transmission. The NC/99-infected donors did not have viral RNA
in lung tissue nor transmitted infection by exhaled aerosol. Thus
higher lung viral RNA titers were not associated with higher
aerosol transmission efficiency among pandemic H1N1 strains, but
a threshold level of virus required for transmission was not
established. Imaginative experimental designs will be needed to
determine the tissue source of exhaled virus.
Airway Culture-negative Lung Infection in Aerosol-
exposed Ferrets
Detection of culture-negative viral RNA in the recipient ferret
airways raised the possibility of either a low level of infection
that was not contagious or that no infection had been
established. Recipient ferrets were necropsied at intervals after
exposure for histological analysis (Table 2) and a sample of
15 lungs containing typical histologic characteristics of influenza
infection were stained for viral antigen by immunohistochem-
istry (IHC). All ferrets with viral RNA in lung tissue after
exposure to the pandemic H1N1 viruses had evidence of
infection although it was graded as either minimal or mild in
most cases. No recipient exposed to the NC/99 virus had
histologic evidence of infection, consistent with the absence of
viral RNA in the lung (Figure 10). Histological evidence of
infection included epithelial karyomegaly and necrosis in
terminal bronchioles with peribronchiolitis, and acute inflam-
mation in the nasal turbinates (Figure 11 A, C, D, E).
Among 9 recipient lungs infected with Cal/04 according to
viral RNA criteria alone, 7 were positive by IHC (Figure 11B).
Of 14 recipient lungs that were viral RNA negative, 9 were
IHC-negative, but 5 were IF-positive. This discrepancy suggests
that in low-level infections the extent of tissue sampling will
Influenza Aerosol Transmission in Ferrets
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culture-negative lung and turbinate infections manifest only by
viral RNA and viral antigen to indicate established but weak
viral replication.
Calculation of the Aerosol Infectious Dose of Pandemic
H1N1 Influenza A
To calculate the aerosol ID50 of Cal/04 for recipients on days 1
and 3 post-exposure, the data were grouped according to the
following criteria: For log10 dose ,1 is group one, 2,log10
dose,=3 is group two, 3,log10 dose,4 is group three, log10 dose
.4 is the group four. For each group, the mean is used as the log10
dose for each group. The Proc Probit procedure in SAS (version
9.0 Cary NC) was used to calculate the infectious dose causing 50
percent of animals to be infected. The log10 dose causing the 50
percent of animals infected is 2.16 (145 genome equivalents). The
95% confidence levels are -1.69 and 2.913 (0.02 and 819 genome
equivalents) (Figure 12). Using the aerosol viral RNA levels and
the viral RNA:viable virus ratio developed previously [32], the
aID50 was estimated at 1 virus particle (95% confidence limits:
0.1–3.0).
Discussion
Our calculation of the minimal infectious dose of exhaled
airborne Cal/04 pandemic virus as approximately 1 FFU is
consistent with studies in ferrets and humans using nebulized virus.
Using the same exposure chambers in this study, we reported the
aerosol ID50 of the H1N1 NC/99 seasonal virus to be 4 pfu [32],
although this NC/99 transmitted infection was detected only by
seroconversion and viral RNA, and not by symptoms or viral
culture. The minimal nebulized H3N2 seasonal virus dose
inducing symptomatic infection in ferrets was 2 pfu by the aerosol
route [31] compared to 1 pfu by the intranasal route. The
minimal aerosol dose by nose-only exposure in ferrets was 1 pfu
for a virulent avian H5N1 strain [37]. Intranasal minimal
infectious dose of an H5N1 strain in mice was 4 pfu [38], and
an H3N2 strain in guinea pigs was 5 pfu [39]. Human volunteers
exposed to a nebulized seasonal H3N2 virus developed symptom-
Figure 7. Comparison of Transmission efficiency of pandemic 2009 H1N1 strains during early and later phases of donor infection.
Single donor-single recipient exposures in which the interval between donor instillation and recipient exposure was varied from 1, 3, or 5 donor dpi.
Viral culture (hatched bar) is expressed as FFU/mL (total sample) of nasal wash collected on day of exposure (donors) or the greatest value found on
day 123 post-exposure (recipients). Aerosol data are expressed as genome equivalents/1-hour filter collection; each of three filters was measured in
triplicate, and the mean of the three filters reported. For each virus: Cal/04 (green), Cal/07 (blue) and Mex/4482 (red), the donor-recipient pair are
aligned horizontally across the figure.
doi:10.1371/journal.pone.0033118.g007
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e33118Figure 8. Efficiency of transmission success is inversely correlated with level of illness in the ferret aerosol-donor. A. Comparison of
percent transmissions detected by positive culture or positive RT-qPCR of nasal washes or throat swabs of recipients tested 123 days post-exposure,
for each strain of pandemic H1N1 2009 influenza A virus. Lack of transmission of NC/99 is shown as left-hand column for comparison. B. Group mean
weight change in the donors following intranasal infection with the three pandemic H1N1 strains. C. Photographs of whole lung tissue at necropsy
(day 5) of donor ferrets infected with Cal/04 (C2, middle photo) or Cal/07 (C1 and C3). Cal/07-infected lungs display multiple regions of firm, dusky
tissue representing pneumonitis confirmed by histology, not seen in Cal/04-infected lungs.
doi:10.1371/journal.pone.0033118.g008
Table 1. Symptoms exhibited by donor ferrets following intranasal infection with one of three pandemic H1N1 strains.
Donors Sign Of Onset NC/99 (N=4) Cal/04 (N=25) Mex/4482 (N=12) Cal/07 (N=10)
Median
a (Range) % Sx
b Median (Range) % Sx Median (Range) % Sx Median (Range) % Sx
Max temp D uC 0.4 (0.6–0) - 0.6 (0–0.8) - 1.0 (0.2–1.4) - 1.3 (0.6–2.1) -
Activity decrease 0 0 0.1 8 0.1 8 0.8 80
Nasal Discharge - - D1 (D1–5) 24 D2 (D1–20) 58 D1 (D-4–18) 100
Neurological - - - - - - D8 (D8–9) 20
Ocular Discharge - - - - - - D3 (D2–11) 40
Sneezing - - - - D8 (D1–19) 50 D2 (D2–9) 50
Stool - - D1 (D1) 12 D2 (D1–19) 41 D2 (D2–11) 80
agroup median for change in temperature or day (D) of onset of symptom and range of days post-infection that symptoms were observed.
bPercent of group with activity decrease or symptom.
doi:10.1371/journal.pone.0033118.t001
Influenza Aerosol Transmission in Ferrets
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e33118atic infection from a calculated mean infectious aerosol dose of 0.3
to 6 TCID50 [40], in contrast to substantially higher minimal doses
by intranasal drops [41]. Although aerosol ID50 measurements for
nebulized versus exhaled virus may not be exactly comparable,
infectious doses transmitted by aerosol appear to be very low. If
influenza transmission among ferrets is comparable to inter-
human transmission, low aerosol infectious doses may have
implications for designing public health interventions.
Measuring aerosol transmissibility in animal models is depen-
dent on the limitations imposed by the experimental conditions.
Brief whole-body exposure between unrestrained, non-anaethe-
tized ferrets was chosen for this study to approximate the
conditions of transmission among humans in their daily activities.
The advantages of this design include natural respiration patterns,
expected dilution of airborne virus by deposition on the inanimate
environment, and exposure to low concentrations of virus in the
aerosol. The disadvantages include inability to exclude exposure
by the non-inhalation routes, loss of aerosolized virus on the
surfaces of the origin chamber, and the need for more surface
decontamination between exposures. These disadvantages are
advantages of the nose-only exposure systems [37,42], but the
reduced minute ventilation of the ferret sleeping in the conical
restraint may alter the mucosal distribution of inhaled virus.
Airborne virus has a low death rate constant if the humidity is low
[43], experimentally confirmed in the guinea pig model by highest
transmission at 20% relative humidity [39,44–46]. Exposures in
this study were conducted at relative humidity of approximately
45%, possibly reducing the efficiency of transmission.
Our chamber designs intentionally limited the exposure to
small-particle exhaled virus, less than 10 mm in the tunneled
chamber and less than 5 mm in the un-tunneled chamber. We
observed no marked difference in transmission efficiency between
the two chambers. In a study of ferrets exposed to exhaled H3N2
virus with a size profile similar to ours [31], the cascade impactor
captured more of the airborne infectious particles in the 4.7 mm
diameter cohort in the two ferrets analyzed. It is possible that our
chambers excluded significant numbers of infectious particles from
reaching the susceptible ferrets, thus reducing culture-positive
infections. Humans exhale droplets of widely varying sizes and
quantity during normal breathing and talking [7,47]. Exhaled
infectious particle size needs further investigation, since virus in
aerosol particles less than 3 mm diameter remain suspended in the
air for an hour or more thus increasing opportunities for aerosol
transmission.
Quantifying aerosol transmissibility in animal models is
dependent on the sensitivity of assays detecting airborne virus.
The PTFE filter used in this study has been shown to be more
efficient than the AGI impinger in capturing viral RNA but less
efficient in capturing infectious particles [48]. During short
collection intervals of 10 min or less both filters [32] and liquid
impingers [31,32] are efficient collectors. However, the marked
variability of exhalation of particles, and presumably virus, over
Figure 9. Exhaled viral RNA from donors infected with either NC/99 (A and B) or Cal/04 (C and D) virus. RNA was measured in each filter
sample by two RT-qPCR-based assays, detecting a single genomic RNA segment (LRRI assay, solid bar) or six segments (Ibis T5000 assay, checkered
bar), and expressed as genome equivalents/1-hour filter collection. Donors were infected intranasally with 10
6 FFU of either virus 24 hours prior to
recipient exposure at a time when all donor nasal washes contained 10
4–10
5 FFU/mL. Each donor exposed three recipient ferrets and each of their
corresponding collections (F1, F2, and F3) were the mean RNA levels from three filters each collecting airborne particles for 1 hour during the 3-hour
exposure period.
doi:10.1371/journal.pone.0033118.g009
Figure 10. Viral loads (RNA genome equivalents per mL nasal
wash or per g lung tissue) for each donor ferret on dpi 1 or dpi
3. Necropsy of donor was performed 2 h after exposing recipient
ferrets. Data combined from 3 experiments indicated by circles,
triangles and diamonds. Lung tissue viral RNA levels for Cal/04 were
mean (SD)=5.94 (2.72) compared to Cal/07+Mex/4482 lung RNA mean
(SD)=8.84 (1.42), significant by t test at p=0.007. Aerosol transmission
success for each virus is exhibited in Figures 4 and 7. The NC/99-
infected donors did not have viral RNA in lung tissue nor transmitted
infection by exhaled aerosol.
doi:10.1371/journal.pone.0033118.g010
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(figure 1, [31]), suggesting that short periods of collection may
not be reliable to capture total exhaled virus levels. In this study
PTFE filter collections for 1 h were rarely culture-positive for
virus and only for the Cal/04 virus, so we elected to use viral
RNA collected during the entire exposure to estimate airborne
virus inhalation. Influenza RNA, but not cultured virus, was
detected in aerosols exhaled from three of five individuals
infected with influenza A [49]. In cough specimens from
subjects with acute influenza A, 81% had viral RNA detected
by M segment RT-qPCR but only 2 of 21 had cultured virus
[47]. We derived the ratio of total viral RNA to infectious
Table 2. Histologic grades of inflammation in respiratory tract tissues of ferrets infected with three pandemic H1N1 viruses.
Histologic grades of inflammation in nasal turbinates and lung tissue
on day 5 or 6 post exposure to exhaled aerosol from donors infected
with virus 24 h prior to exposure. Cal/04 Cal/07 Mex/4482
Number of recipient ferrets with histological alterations in the respiratory tract (%) 14/15 3/4 4/4
93% 75% 100%
Nasal Cavity Inflammation, acute 14 3 4
Minimal 14 3 3
Moderate 00 1
Lung Bronchiole Inflammation, acute 9 1 3
Minimal 41 2
Mild 20 1
Moderate 30 0
Pneumonitis, interstitial
b 12 2 3
Minimal 52 2
Mild 70 1
doi:10.1371/journal.pone.0033118.t002
Figure 11. Histology of lung and turbinates from exhaled aerosol-exposed recipient ferrets infected with Cal/04. a,d: Mild focal
bronchiolitis with epithelial cell karyomegaly and desquamated epithelium and neutrophil inflammatory cells in the lumen of small airways (solid
arrows). b. Immunohistochemical detection of influenza nucleoprotein antigen in airway epithelial cells. c,d,e. Intramucosal and submucosal
inflammatory cells in the turbinate (c) and peribronchial tissue (d,e).
doi:10.1371/journal.pone.0033118.g011
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20 minutes [32]. The lower ratio calculated using cascade
impactors [32] may be due to destruction of intact genomic
RNA [48]. Ratios of RNA genome equivalents to infectious
virions have been subject to wide experimental variation. Viral
particles secreted into tissue culture media consists primarily of
non-infectious (defective interfering) particles among only 1%
infectious particles [50–52]. Future work must address these
technical limitations of quantifying low levels of aerosol
infectious particles.
Continuous exposures to exhaled aerosols with seasonal and
pandemic strains have resulted in culture-positive infections and
seroconversions [23–30]. In this study, however, neither
symptoms nor culture-positive airways were commonly docu-
mented. Seroconversion was not used in this study because lung
histopathology and viral load was examined during the first
week after exposures. Many exposed ferrets with negative
airway cultures had viral RNA-positive airways for 5 days after
exposure. This observation was interpreted to indicate estab-
lished mucosal infection, since UV-inactivated viral RNA
deposited on ferret mucosa is cleared and undetectable within
24h [32]. We documented established lung infection with the
pandemic H1N1, but not seasonal H1N1, viruses by immuno-
histochemical detection of viral antigen in culture-negative, viral
RNA-positive ferrets. Nonetheless the culture-negative infections
likely indicate that the viruses studied were significantly less
virulent than that reported for the H3N2 strain [31]. Whether
3 h exposures to less virulent strains are contagious and provide
immunologically relevant exposure should be tested.
We compared three closely related pandemic 2009 H1N1
viruses for aerosol transmissibility and virulence. Intranasal
infection with Cal/07 and Mex/4482 clearly induced greater
morbidity, fever, weight loss, sneezing, and decreased activity,
which were all absent in the ferrets infected with Cal/04. The
greater morbidity of Cal/07 has been observed previously [53]
as has the mild morbidity in ferret Cal/04 infections [29]. The
genomic basis for this virulence heterogeneity is unknown, as
only four nucleotide differences among the eight RNA segments
were found between the Cal/04 and Cal/07 stocks we used (P
Gao, unpublished data). Single nucleotide mutations in the
hemagglutinin, neuraminidase, and PB2 segments have been
shown to alter transmissibility [21,23–27], but these mutations
were not present in the strain isolates studied here.
The two more virulent strains were less efficiently transmitted
using the criteria of few culture-positive recipients, yet upper
airway donor viral loads were similar among the three
pandemic viruses. Moreover the levels of viral RNA in exhaled
aerosols were also comparable. We speculate that either the
donor’s mucosal inflammatory response diminished exhalation
of viable virus, not distinguished by a viral RNA assay, or that
aerosol-derived infection was a function of the relative
replication efficiency of virulent virus strains in susceptible
respiratory mucosa. In a recent study [54] we used computa-
tional modeling of viral kinetics in human tracheal epithelial
cells to derive estimates of strain-specific viral productivity per
infected cell and the spread of virus from a primary to
secondarily infected cells (basic reproductive number R0). The
replication efficiency of the pandemic Cal/04 strain was 5210-
fold greater than the seasonal NC/99 strain [54]. Similar
differences between replication rates have been documented in
ferret tracheal epithelial cells (unpublished data). Thus, success-
ful transmission from contagious to susceptible ferret may
depend as much on the replication efficiency of the virus strain
as on the inhaled dose of viable virus and other virus-host
relationships.
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